CIBC World Markets’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.9M | Buy |
+80,960
| New | +$6.64M | 0.03% | 335 |
|
|
2025
Q2 | $5.77M | Buy |
73,780
+2,640
| +4% | +$197K | 0.04% | 343 |
|
|
2025
Q1 | $5.16M | Sell |
71,140
-22,505
| -24% | -$1.61M | 0.04% | 298 |
|
|
2024
Q4 | $6.93M | Buy |
93,645
+11,873
| +15% | +$831K | 0.04% | 291 |
|
|
2024
Q3 | $5.4M | Buy |
81,772
+4,220
| +5% | +$307K | 0.04% | 310 |
|
|
2024
Q2 | $7.16M | Buy |
77,552
+16,736
| +28% | +$1.48M | 0.05% | 254 |
|
|
2024
Q1 | $5.81M | Sell |
60,816
-17,294
| -22% | -$1.45M | 0.04% | 287 |
|
|
2023
Q4 | $5.96M | Buy |
78,110
+44,557
| +133% | +$3.1M | 0.03% | 307 |
|
|
2023
Q3 | $2.32M | Sell |
33,553
-37,501
| -53% | -$3.01M | 0.02% | 353 |
|
|
2023
Q2 | $6.7M | Buy |
71,054
+39,789
| +127% | +$3.46M | 0.05% | 235 |
|
|
2023
Q1 | $2.59M | Sell |
31,265
-41,421
| -57% | -$3.26M | 0.04% | 291 |
|
|
2022
Q4 | $5.42M | Buy |
72,686
+63,279
| +673% | +$4.88M | 0.04% | 311 |
|
|
2022
Q3 | $777K | Sell |
9,407
-33,997
| -78% | -$3.27M | 0.01% | 393 |
|
|
2022
Q2 | $4.13M | Sell |
43,404
-85,037
| -66% | -$8.8M | 0.04% | 245 |
|
|
2022
Q1 | $15.1M | Buy |
128,441
+10,696
| +9% | +$1.2M | 0.12% | 130 |
|
|
2021
Q4 | $15.3M | Sell |
117,745
-22,904
| -16% | -$2.67M | 0.08% | 148 |
|
|
2021
Q3 | $15.9M | Buy |
140,649
+97,487
| +226% | +$11.1M | 0.11% | 135 |
|
|
2021
Q2 | $4.47M | Sell |
43,162
-16,381
| -28% | -$1.54M | 0.03% | 280 |
|
|
2021
Q1 | $4.98M | Sell |
59,543
-276,529
| -82% | -$23.4M | 0.03% | 292 |
|
|
2020
Q4 | $30.7M | Buy |
336,072
+199,459
| +146% | +$16.5M | 0.15% | 110 |
|
|
2020
Q3 | $10.9M | Buy |
136,613
+75,762
| +125% | +$5.91M | 0.11% | 184 |
|
|
2020
Q2 | $4.21M | Buy |
60,851
+15,056
| +33% | +$1.07M | 0.05% | 277 |
|
|
2020
Q1 | $2.88M | Sell |
45,795
-76,182
| -62% | -$5.49M | 0.04% | 285 |
|
|
2019
Q4 | $9.48M | Sell |
121,977
-102,408
| -46% | -$8M | 0.06% | 262 |
|
|
2019
Q3 | $16.4M | Buy |
224,385
+81,459
| +57% | +$5.72M | 0.15% | 155 |
|
|
2019
Q2 | $8.8M | Sell |
142,926
-6,273
| -4% | -$379K | 0.07% | 295 |
|
|
2019
Q1 | $9.52M | Sell |
149,199
-54,201
| -27% | -$3.09M | 0.08% | 229 |
|
|
2018
Q4 | $10.4M | Buy |
203,400
+29,706
| +17% | +$1.5M | 0.1% | 199 |
|
|
2018
Q3 | $10.1M | Buy |
173,694
+33,162
| +24% | +$1.62M | 0.09% | 217 |
|
|
2018
Q2 | $6.82M | Buy |
140,532
+23,727
| +20% | +$1.11M | 0.06% | 300 |
|
|
2018
Q1 | $5.43M | Sell |
116,805
-24,597
| -17% | -$1.07M | 0.06% | 271 |
|
|
2017
Q4 | $5.31M | Buy |
141,402
+44,034
| +45% | +$1.62M | 0.04% | 323 |
|
|
2017
Q3 | $3.55M | Sell |
97,368
-105,570
| -52% | -$4.03M | 0.03% | 341 |
|
|
2017
Q2 | $8M | Buy |
202,938
+136,422
| +205% | +$4.98M | 0.08% | 223 |
|
|
2017
Q1 | $2.09M | Sell |
66,516
-340,530
| -84% | -$10.7M | 0.02% | 370 |
|
|
2016
Q4 | $12.7M | Buy |
+407,046
| New | +$13.2M | 0.13% | 156 |
|
|
2016
Q2 | – | Sell |
-13,113
| Closed | -$386K | – | 238 |
|
|
2016
Q1 | $386K | Buy |
+13,113
| New | +$362K | 0.01% | 214 |
|
Other funds holding EW
CIBC World Markets's EW Position: Q4 2025 in Review
CIBC World Markets opened a new position in Edwards Lifesciences (EW) in Q4 2025: 80,960 shares worth $6.9M. The stake represents 0.03% of the portfolio and ranks #335 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in EW as recently as Q2 2025.
CIBC World Markets first reported a position in EW in Q1 2016 and has held it in 37 quarters since. The position peaked at $30.7M in Q4 2020. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.
- CIBC World Markets held 80,960 shares of Edwards Lifesciences worth $6.9M as of Q4 2025.
- Edwards Lifesciences was a new CIBC World Markets position in Q4 2025.
- Edwards Lifesciences made up 0.03% of CIBC World Markets's portfolio in Q4 2025, its #335 holding.
- CIBC World Markets first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 37 quarters since.
- CIBC World Markets's Edwards Lifesciences position peaked at $30.7M in Q4 2020.
- 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.